(01/09/18) Top Picks 2018: MannKind (MNKD)
After receiving a very positive label change for its lead product, Afrezza (an inhalable form of insulin), late in the year, MannKind (MNKD) also raised a sizable chunk of cash, notes Nate Pile,...
moneyshow.com